Skip to main content

BLKB expanding support for startups

| News

BLKB expanding support for startups

12.01.2023

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies now have another opportunity to weigh up: From now on, they have the option of converting their loan into equity financing.

BLKB, the cantonal bank for the canton of Basel-Landschaft, is expanding its support program for innovative SMEs and startups. In future, BLKB will offer companies regarded as particularly promising from the “100 fürs Baselbiet” promotional program the opportunity to convert their loan into equity financing, further details of which can be found in a press release. BLKB cites a high degree of innovation, strong scalability and a successful due diligence check as prerequisites for this.

At the start of 2020, BLKB launched the “100 fürs Baselbiet” initiative in conjunction with the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) and Economic Development Baselland. The aim of this project is to enable 100 companies with a link to the canton of Basel-Landschaft, colloquially referred to as the Baselland or Baselbiet, to take a decisive step forward in their further development.

Already 37 companies supported

BLKB board member Beat Röthlisberger is “very proud that after three years we can already support 37 innovative companies in their next development step”. As a result, these companies have been able to create 120 new jobs. Currently, the 37 companies are supported with a total amount of 13.7 million Swiss francs as well as extensive consulting services. In order to reinforce the positive effect, BLKB is now scaling up its commitment.

Together with the Baselland Chamber of Commerce and FHNW, the BLKB also organizes the Swiss Innovation Challenge. According to Arie Verkuil, who heads up the FHNW Institute of Management, a total of 850 applications with business concepts have been submitted in eight years. This shows that “the potential for further interested companies is definitely there”.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.